Mabcampath and multi-organ failure Patient Reports February 11, 2012

Mabcampath Side Effects Report #5777966-0
Mabcampath side effect was reported by a Pharmacist from NETHERLANDS on June 09, 2008. Male patient, 62 years of age, weighting 187.4 lb, was diagnosed with t-cell depletion, bone marrow conditioning regimen and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , epstein-barr virus infection, multi-organ failure, pneumonia cytomegaloviral, post transplant lymphoproliferative disorder. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, BUSULPHAN. Patient died on 03/08/2008.

Mabcampath Side Effects Report #5779911-0
Mabcampath side effect was reported by a Pharmacist from NETHERLANDS on June 09, 2008. Male patient, 62 years of age, weighting 187.4 lb, was diagnosed with t-cell depletion, bone marrow conditioning regimen and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , epstein-barr virus infection, multi-organ failure, pneumonia cytomegaloviral, post transplant lymphoproliferative disorder. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, BUSULPHAN. Patient died on 03/08/2008.

Mabcampath Side Effects Report #5940185-9
Mabcampath side effect was reported by a Pharmacist from UNITED STATES on June 09, 2008. Male patient, 62 years of age, weighting 187.4 lb, was diagnosed with t-cell depletion, bone marrow conditioning regimen and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection, multi-organ failure, pneumonia cytomegaloviral. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARA, BUSULPHAN. Patient died on 03/08/2008.

Mabcampath Side Effects Report #5822083-4
Mabcampath side effect was reported by a Pharmacist from UNITED STATES on June 09, 2008. Female patient, 47 years of age, weighting 114.6 lb, was diagnosed with bone marrow conditioning regimen and was treated with Mabcampath. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , epstein-barr virus associated lymphoproliferative disorder, epstein-barr virus infection, multi-organ failure. Mabcampath dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, BUSULFAN. Patient died on 05/25/2007.